A modified drug combination may lead to a decreased chance of disease recurrence for women with high risk, HER-2 negative breast cancer.
Oncologists echo findings that suggest a reduced risk of breast cancer recurrence
Brabus Launches ‘Deep Blue’ G-Wagon, Speedboat & Luxury Watch Line
Brabus is unifying its collaborations with Mercedes-AMG, Finland’s Axopar Boats, and Panerai luxury watches under one Deep Blue collection.Being that Brabus is...
